ANIK logo

Anika Therapeutics (ANIK) Return On Equity

Annual ROE

-33.21%
-28.02%-539.88%

December 31, 2023


Summary


Performance

ANIK ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKprofitabilitymetrics:

Quarterly ROE

-45.09%
-13.54%-42.92%

September 30, 2024


Summary


Performance

ANIK Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ANIK ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-539.9%0.0%
3 y3 years-288.4%-2121.2%
5 y5 years-567.8%-486.0%

ANIK ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2343.9%at low-3188.4%at low
5 y5-year-437.2%at low-538.2%at low
alltimeall time-171.7%+26.8%-195.3%+15.8%

Anika Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
-45.09%(+42.9%)
Jun 2024
-
-31.55%(+2.1%)
Mar 2024
-
-30.91%(-1.3%)
Dec 2023
-33.21%(+539.9%)
-31.32%(+255.1%)
Sep 2023
-
-8.82%(+12.1%)
Jun 2023
-
-7.87%(+0.4%)
Mar 2023
-
-7.84%(+50.8%)
Dec 2022
-5.19%(-450.7%)
-5.20%(-5.3%)
Sep 2022
-
-5.49%(+43.3%)
Jun 2022
-
-3.83%(+571.9%)
Mar 2022
-
-0.57%(-139.0%)
Dec 2021
1.48%(-117.3%)
1.46%(-171.9%)
Sep 2021
-
-2.03%(-55.0%)
Jun 2021
-
-4.51%(-52.6%)
Mar 2021
-
-9.51%(+13.2%)
Dec 2020
-8.55%(-186.8%)
-8.40%(+463.8%)
Sep 2020
-
-1.49%(-136.9%)
Jun 2020
-
4.04%(-60.7%)
Mar 2020
-
10.29%(+2.5%)
Dec 2019
9.85%(+38.7%)
10.04%(-14.0%)
Sep 2019
-
11.68%(+2.6%)
Jun 2019
-
11.38%(-1.2%)
Mar 2019
-
11.52%(+59.1%)
Dec 2018
7.10%(-45.8%)
7.24%(-2.7%)
Sep 2018
-
7.44%(+3.0%)
Jun 2018
-
7.22%(-7.8%)
Mar 2018
-
7.83%(-40.3%)
Dec 2017
13.09%(-12.8%)
13.11%(-4.1%)
Sep 2017
-
13.67%(-10.0%)
Jun 2017
-
15.19%(+4.1%)
Mar 2017
-
14.59%(-6.1%)
Dec 2016
15.01%(-5.1%)
15.53%(-10.3%)
Sep 2016
-
17.32%(-0.7%)
Jun 2016
-
17.45%(0.0%)
Mar 2016
-
17.45%(+9.1%)
Dec 2015
15.82%(-35.2%)
16.00%(+7.0%)
Sep 2015
-
14.96%(+4.3%)
Jun 2015
-
14.35%(-9.1%)
Mar 2015
-
15.79%(-33.9%)
Dec 2014
24.43%(+45.2%)
23.88%(-3.3%)
Sep 2014
-
24.69%(-3.5%)
Jun 2014
-
25.59%(+2.6%)
Mar 2014
-
24.93%(+46.6%)
Dec 2013
16.83%(+45.8%)
17.00%(+5.9%)
Sep 2013
-
16.05%(+16.1%)
Jun 2013
-
13.82%(+12.2%)
Mar 2013
-
12.32%(+6.1%)
Dec 2012
11.54%(+22.6%)
11.61%(+11.8%)
Sep 2012
-
10.38%(-13.8%)
Jun 2012
-
12.04%(+11.3%)
Mar 2012
-
10.82%(+15.4%)
Dec 2011
9.41%(+82.4%)
9.38%(+19.3%)
Sep 2011
-
7.86%(+30.8%)
Jun 2011
-
6.01%(+28.1%)
Mar 2011
-
4.69%(-10.3%)
Dec 2010
5.16%(0.0%)
5.23%(+12.0%)
Sep 2010
-
4.67%(-13.4%)
Jun 2010
-
5.39%(-2.4%)
Mar 2010
-
5.52%(-0.9%)
Dec 2009
5.16%(-17.7%)
5.57%(-16.0%)
Sep 2009
-
6.63%(+8.9%)
Jun 2009
-
6.09%(+1.8%)
Mar 2009
-
5.98%(-4.6%)
Dec 2008
6.27%
6.27%(-16.2%)
DateAnnualQuarterly
Sep 2008
-
7.48%(-16.9%)
Jun 2008
-
9.00%(-13.5%)
Mar 2008
-
10.41%(-13.4%)
Dec 2007
12.02%(+8.9%)
12.02%(+6.7%)
Sep 2007
-
11.27%(+4.5%)
Jun 2007
-
10.78%(-4.4%)
Mar 2007
-
11.28%(+2.3%)
Dec 2006
11.04%(-36.1%)
11.03%(+0.8%)
Sep 2006
-
10.94%(-25.3%)
Jun 2006
-
14.64%(-4.9%)
Mar 2006
-
15.39%(-10.3%)
Dec 2005
17.27%(-62.7%)
17.16%(-18.7%)
Sep 2005
-
21.11%(+23.5%)
Jun 2005
-
17.10%(+5.9%)
Mar 2005
-
16.14%(-62.8%)
Dec 2004
46.29%(+880.7%)
43.43%(-1.9%)
Sep 2004
-
44.26%(-5.4%)
Jun 2004
-
46.79%(-1.1%)
Mar 2004
-
47.31%(+879.5%)
Dec 2003
4.72%(-128.9%)
4.83%(-5.1%)
Sep 2003
-
5.09%(-281.1%)
Jun 2003
-
-2.81%(-68.9%)
Mar 2003
-
-9.04%(-47.1%)
Dec 2002
-16.36%(-43.3%)
-17.08%(-26.9%)
Sep 2002
-
-23.38%(-3.5%)
Jun 2002
-
-24.24%(-18.2%)
Mar 2002
-
-29.65%(-0.2%)
Dec 2001
-28.87%(-4474.2%)
-29.71%(+76.8%)
Sep 2001
-
-16.80%(+2.9%)
Jun 2001
-
-16.32%(+161.1%)
Mar 2001
-
-6.25%(-1019.1%)
Dec 2000
0.66%(-107.7%)
0.68%(-103.3%)
Sep 2000
-
-20.48%(+37.3%)
Jun 2000
-
-14.92%(+22.7%)
Mar 2000
-
-12.16%(+38.7%)
Dec 1999
-8.55%(-163.1%)
-8.77%(-385.7%)
Sep 1999
-
3.07%(-43.0%)
Jun 1999
-
5.39%(-53.5%)
Mar 1999
-
11.59%(-9.5%)
Dec 1998
13.55%(-35.9%)
12.80%(-52.5%)
Sep 1998
-
26.97%(-6.3%)
Jun 1998
-
28.77%(+13.6%)
Mar 1998
-
25.32%(-21.2%)
Dec 1997
21.15%(-146.6%)
32.13%(-379.9%)
Sep 1997
-
-11.48%(-42.9%)
Jun 1997
-
-20.12%(-43.5%)
Mar 1997
-
-35.60%(-33.5%)
Dec 1996
-45.38%(+2.9%)
-
Nov 1996
-
-53.57%(+12.0%)
Aug 1996
-
-47.85%(-1.0%)
Aug 1996
-44.09%(+23.5%)
-
May 1996
-
-48.33%(-6.4%)
Feb 1996
-
-51.66%(+35.8%)
Nov 1995
-
-38.04%(+5.0%)
Aug 1995
-35.71%(+54.3%)
-36.23%(+25.5%)
May 1995
-
-28.88%(-0.7%)
Feb 1995
-
-29.09%(+6.6%)
Nov 1994
-
-27.30%(+30.2%)
Aug 1994
-23.14%(-3.1%)
-20.97%(+6.1%)
May 1994
-
-19.76%(+11.1%)
Feb 1994
-
-17.78%(+22.1%)
Nov 1993
-
-14.56%(+13.2%)
Aug 1993
-23.88%
-12.86%(+134.7%)
May 1993
-
-5.48%

FAQ

  • What is Anika Therapeutics annual return on equity?
  • What is the all time high annual ROE for Anika Therapeutics?
  • What is Anika Therapeutics annual ROE year-on-year change?
  • What is Anika Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Anika Therapeutics?
  • What is Anika Therapeutics quarterly ROE year-on-year change?

What is Anika Therapeutics annual return on equity?

The current annual ROE of ANIK is -33.21%

What is the all time high annual ROE for Anika Therapeutics?

Anika Therapeutics all-time high annual return on equity is 46.29%

What is Anika Therapeutics annual ROE year-on-year change?

Over the past year, ANIK annual return on equity has changed by -28.02% (-539.88%)

What is Anika Therapeutics quarterly return on equity?

The current quarterly ROE of ANIK is -45.09%

What is the all time high quarterly ROE for Anika Therapeutics?

Anika Therapeutics all-time high quarterly return on equity is 47.31%

What is Anika Therapeutics quarterly ROE year-on-year change?

Over the past year, ANIK quarterly return on equity has changed by 0.00% (0.00%)